Rifampicin Resistance: Fitness Costs and the Significance of Compensatory Evolution
Seventy years after the introduction of antibiotic chemotherapy to treat tuberculosis, problems caused by drug-resistance in Mycobacterium tuberculosis have become greater than ever. The discovery and development of novel drugs and drug combination therapies will be critical to managing these proble...
Saved in:
Main Authors: | Gerrit Brandis (Author), Diarmaid Hughes (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2013-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cost-effectiveness of short, oral treatment regimens for rifampicin resistant tuberculosis
by: Sedona Sweeney, et al.
Published: (2022) -
Cost-effectiveness of short, oral treatment regimens for rifampicin resistant tuberculosis.
by: Sedona Sweeney, et al.
Published: (2022) -
Low-cost rapid detection of rifampicin resistant tuberculosis using bacteriophage in Kampala, Uganda
by: Smith Peter G, et al.
Published: (2007) -
Plasmid Costs Explain Plasmid Maintenance, Irrespective of the Nature of Compensatory Mutations
by: João S. Rebelo, et al.
Published: (2023) -
Mutations inside rifampicin-resistance determining region of rpoB gene associated with rifampicin-resistance in Mycobacterium tuberculosis
by: Myo T. Zaw, et al.
Published: (2018)